Muscular Dystrophy News: A Look Back at 2017

With the holiday season in full swing, it’s the perfect opportunity to take a look back at 2017.

It’s been a year full of ups and downs, and while there were definitely quite a few low moments, there were certainly quite a few highs.

To celebrate the year that was, here are a few of our most popular stories of the year:

CRISPR-Cpf1 Corrects Duchenne Mutations, Restores Dystrophin Expression, UT Study Shows

Resolaris Improves Muscle Strength, Quality of Life in FSHD Patients, Study Finds

Apabetalone May Repress Toxic Gene in Rare Muscular Dystrophy (FSHD)


We hope you enjoy — and we wish you all the best in 2018.

Muscular Dystrophy News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.


  1. Tonina Del Papa D'Ambrosio says:

    Hi,I appreciate all your great work! It looks like research is progressing very well to improve special treatments for some types of muscular dystrophy. One question: Is there anything progressing for LGMD (Limb Girdle Muscular Dystrophy?) Would Resolaris help to strengthen muscles for this type of Dystrophy?
    I take this opportunity to wish you al a very exceptional HAPPY NEW YEAR!

Leave a Comment

Your email address will not be published. Required fields are marked *